Monday, 22 August 2016

Medivation Ovation: Pfizer Pays the Price for Growth

Pfizer’s $14 billion acquisition shows quality midsize biotechs are in short supply.

from WSJ.com: Markets http://ift.tt/2buLBq8
via https://ifttt.com/ IFTTT
Posted by at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)